US 11000595
Modulators of PCSK9 expression
granted A61KA61K31/7115A61K31/712
Quick answer
US patent 11000595 (Modulators of PCSK9 expression) held by Ionis Pharmaceuticals, Inc. expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/7115, A61K31/712, A61K31/7125, A61K47/549